bluebird bio Inc (NAS:BLUE)
$ 0.6078 0.0338 (5.89%) Market Cap: 117.15 Mil Enterprise Value: 240.30 Mil PE Ratio: 0 PB Ratio: 0.29 GF Score: 25/100

bluebird bio Inc at Cowen HealthCare Conference Transcript

Mar 03, 2020 / 01:00PM GMT
Release Date Price: $46.1 (-3.55%)
Yaron Benjamin Werber
Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst

Okay, and thank you for joining us for the 40th Annual Cowen Health Care Conference in Boston. I'm Yaron Werber, a Biotech Analyst at Cowen. And it's a great pleasure to do a fireside chat with bluebird. To my left is Nick Leschly, who is the Chief bluebird; and then to his left is Dave Davidson, who is the Chief Medical bluebird.

Nick Leschly
bluebird bio, Inc. - President, CEO & Director

Chief (inaudible).

Yaron Benjamin Werber
Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst

Chief Medical bird. So we're going to start with Nick, I think you have a few slides to kind of kick it off, and then we're going to go into a fireside chat. Thank you for joining us.

Nick Leschly
bluebird bio, Inc. - President, CEO & Director

Yes. Thank you for having us. It is always good to come here to Cowen, especially if the travel is fairly

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot